2m 2m 2m 2m 2m 2m 2m
CEL-SCI (CVM)
NYSE
$2.31+$0.22 (+10.53%)
Price as of Oct 02, 2026 7:30 PM EDT- $36.8MMarket Cap
- -79.43%1-Year Change
- BiotechnologyIndustry
CEL-SCI (CVM)
$2.31+$0.22 (+10.53%)
CVM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.09 | ||
Change | +$0.03 (+1.46%) | ||
Open | $2.06 | ||
High | $2.30 | ||
Low | $1.96 | ||
Previous Close | $2.06 | ||
Volume | 810,343 | ||
30-Day Average Volume | 158,581 | ||
1-Week Change | 21.51% | ||
1-Month Change | 29.81% | ||
1-Year Change | -79.43% | ||
3-Year Change | -94.43% | ||
5-Year Change | -99.39% | ||
Fundamentals | |||
Shares Outstanding | 17.6M | ||
Total Assets | $21.4M | ||
Market Cap | $36.8M | ||
Enterprise Value | $30.2M | ||
Period: QTR TTM FY | |||
Revenue | -$110,240.00 | ||
Net Income | -$5.7M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$5.6M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $2.4M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | -274 | ||
P/B | 3 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 05/20/2025 | ||